Recent Quotes (30 days)

You have no recent quotes
chg | %

SAGE Therapeutics Inc financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2017-06-30 3 months ending 2017-03-31 3 months ending 2016-12-31 3 months ending 2016-09-30 3 months ending 2016-06-30
Revenue - - - - -
Other Revenue, Total - - - - -
Total Revenue 0.00 0.00 0.00 0.00 0.00
Cost of Revenue, Total - - - - -
Gross Profit - - - - -
Selling/General/Admin. Expenses, Total 14.95 12.28 14.37 8.99 8.91
Research & Development 55.90 45.20 42.00 29.07 26.10
Depreciation/Amortization - - - - -
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) - - - - -
Other Operating Expenses, Total - - - - -
Total Operating Expense 70.85 57.48 56.38 38.06 35.01
Operating Income -70.85 -57.48 -56.38 -38.06 -35.01
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net -0.02 -0.01 -0.02 -0.01 -0.01
Income Before Tax -70.20 -56.78 -55.90 -37.80 -34.75
Income After Tax -70.20 -56.78 -55.90 -37.80 -34.75
Minority Interest - - - - -
Equity In Affiliates - - - - -
Net Income Before Extra. Items -70.20 -56.78 -55.90 -37.80 -34.75
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income -70.20 -56.78 -55.90 -37.80 -34.75
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items -70.20 -56.78 -55.90 -37.80 -34.75
Income Available to Common Incl. Extra Items -70.20 -56.78 -55.90 -37.80 -34.75
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment - - - - -
Diluted Weighted Average Shares 37.36 37.27 37.32 32.98 32.06
Diluted EPS Excluding Extraordinary Items -1.88 -1.52 -1.50 -1.15 -1.08
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue 0.00 0.00 - 0.00 0.00
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS -1.88 -1.52 -1.50 -1.15 -1.08